Make Science Really International

Internationalize science? Isn't it a!lready international? Not at all. Countries representing only one-quarter of the world's population produce 95 percent of the new science, while the remaining three-quarters contribute only 5 percent. We are, in effect, leaving three-quarters of human brain power unused. Science would progress much faster were this not so. Given the intimate connecbetween science, technology, production and standard of living, a universalization of science would also alleviat

Written byMichael Moravcsik
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Not at all. Countries representing only one-quarter of the world's population produce 95 percent of the new science, while the remaining three-quarters contribute only 5 percent. We are, in effect, leaving three-quarters of human brain power unused. Science would progress much faster were this not so. Given the intimate connecbetween science, technology, production and standard of living, a universalization of science would also alleviate many of the world's problems.

It has been said that the Third World cannot afford to evolve its own science. Yet money is not the main problem. Currently, developing countries spend about $1 billion a year (hardly a negligible sum), which is only .1 percent of their gross national products. Such an outlay hardly makes an impact on their spending in other areas.

The real problem is people. The establishment of a large, well-educated cadre of scientists with a tradition behind them is a long-term project ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies